{
  "schemaVersion": 1,
  "id": "research-306",
  "slug": "306-what-a-receptor-structure-can-explain-about-pt-141",
  "title": "What a Receptor Structure Can Explain About PT-141",
  "catalogLabel": "PT-141",
  "productCollection": "https://heritagebiolabs.com/research-library/products/pt-141",
  "productHandles": [
    "pt-141-449"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/pt-141-449"
  ],
  "readingFocus": "Mechanisms & biology",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 266,
  "sourceYears": [
    2021,
    2026
  ],
  "paragraphs": [
    "A peptide is a short amino-acid chain linked by peptide bonds. The shape of a chain helps determine how it fits into a receptor. Bremelanotide, also called PT-141, is a cyclic peptide in the melanocortin research family. The current US label describes it as a melanocortin receptor agonist. An older direct structural study lets researchers see how it interacted with one member of that family, the melanocortin-4 receptor, or MC4R. [1, 2]",
    "Huibing Zhang and colleagues used cryogenic electron microscopy to observe MC4R in an active complex with a signaling protein. They compared structures obtained with several molecules bound, including a naturally occurring peptide signal, bremelanotide, another peptide drug and a small molecule. Some peptide agonists occupied the receptor in related ways. The small molecule showed a different pattern of interactions. These comparisons help explain how different compounds can activate the receptor without all fitting in exactly the same way. [2]",
    "A receptor structure captures a selected state under study conditions. It can help researchers identify interactions to investigate further. It does not measure a person's desire, distress or response to treatment. It also cannot determine by itself how much a receptor in a given tissue contributes to the clinical response. The label describes melanocortin receptor activity while distinguishing it from an established clinical mechanism for the labeled condition. [1, 2]",
    "The structural paper is included because it directly visualized a complex with bremelanotide. It supplies evidence about binding and signaling at a receptor, alongside a different body of evidence for patient outcomes. Keeping those lines of evidence separate makes both easier to interpret. [1, 2]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "US Food and Drug Administration. Vyleesi (bremelanotide) prescribing information. Drugs@FDA (revised 2026-10).",
      "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/210557s005lbl.pdf"
    },
    {
      "number": 2,
      "citation": "Zhang H et al. Structural insights into ligand recognition and activation of the melanocortin-4 receptor. Cell Research (online 2021-08-25).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/34433901/"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/306-what-a-receptor-structure-can-explain-about-pt-141",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/306-what-a-receptor-structure-can-explain-about-pt-141.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/306-what-a-receptor-structure-can-explain-about-pt-141.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 062 - PT-141 and RETA GLP-3.docx",
    "sourceArticleNumber": 306,
    "contentSha256": "4586db998d45136f2edc998880b43a53c2c26372c011781ca0c57616de6fc6bf",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
